Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.

Familial cancer - 1 Dec 2010

Vargas Ana Cristina, Da Silva Leonard, Lakhani Sunil R

Abstract excerpt

BRCA1 and BRCA2 associated breast cancer comprises a small but important group of hereditary breast cancer. Testing for BRCA1 and BRCA2 has significant clinical and personal implications for the patients in terms of therapy and follow-up of individual family members. The sequencing of the genes is expensive and since the information derived may have a profound effect on the individual and family members, it is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to Heterozygote

Share to Models, Statistical

Source

Identifiers

PMID: 20577821
DOI: 10.1007/s10689-010-9362-5

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.PMID 20577821Read ↗

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesSemantic proximity Read ↗

Incorporating tumour pathology information into breast cancer risk prediction algorithms.Semantic proximity Read ↗

Recent developments in the ability to predict and modify breast cancer risk.Semantic proximity Read ↗

Pathology of hereditary breast cancer.Semantic proximity Read ↗

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers.Semantic proximity Read ↗

Risk prediction models for familial breast cancer.Semantic proximity Read ↗

Tumor characteristics and prognosis in familial breast cancer.Semantic proximity Read ↗

The genetics of breast cancer susceptibility.Semantic proximity Read ↗

Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.Semantic proximity Read ↗

Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.Semantic proximity Read ↗

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier predictionSemantic proximity Read ↗

The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.